NICE IDs

11/10/2021

ID1483: Roxadustat for treating anaemia in people with chronic kidney disease

11/10/2021

ID3839: Cemiplimab for untreated PD-L1-postive advanced or metastatic non-small-cell lung cancer

11/10/2021

ID1570: Odevixibat for treating progressive familial intrahepatic cholestasis

11/10/2021

ID1065: Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea

11/10/2021

ID3842: Relugolix with oestradiol and norethisterone acetate for treating uterine fibroids

11/10/2021

ID3764: Setmelanotide for treating obesity caused by LEPR or POMC deficiency

11/10/2021

ID1676: Nivolumab for adjuvant treatment of oesophageal or gastro-oesophageal junction cancer

01/06/2021

ID3835: Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection

01/06/2021

ID1605: Enzalutamide for treating hormone-sensitive metastatic prostate

03/12/2020

ID1669: Secukinumab for treating moderate to severe plaque psoriasis in children and young people

30/11/2020

ID1680: Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

30/11/2020

ID1622: Baricitinib for treating moderate to severe atopic dermatitis

30/11/2020

ID2728: Bupivacaine–meloxicam for treating postoperative pain

23/11/2020

ID1598: Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

06/11/2020

ID3878: Upadacitinib for previously treated moderate active rheumatoid arthritis

06/11/2020

ID1400: Upadacitinib for treating severe rheumatoid arthritis

30/10/2020

ID740: Liraglutide for managing overweight and obesity

23/10/2020

ID1443: Darolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer

14/10/2020

ID3732: Bulevirtide for treating chronic hepatitis D

12/10/2020

ID885: Short bowel syndrome - teduglutide